Citadel Advisors »

Neuphoria Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $79k 19k 4.07
2025-06-30 $104k 15k 7.10

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Neuphoria Therapeutics

Lynx1 Capital Management
AdvisorShares Investments
Shay Capital
Balyasny Asset Management
Squadron Capital Management
Geode Capital Management
Diadema Partners
Ikarian Capital
Vanguard Fiduciary Trust
ADAR1 Capital Management
FNY Investment Advisers
Vanguard Group
Citadel Advisors
Bridgeway Capital Management
Boothbay Fund Management

View all funds holding Neuphoria Therapeutics